$2.43 Billion is the total value of SECTORAL ASSET MANAGEMENT INC's 64 reported holdings in Q1 2014. The portfolio turnover from Q4 2013 to Q1 2014 was 32.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMGN | Buy | AMGEN INC | $173,300,000 | +20.3% | 1,405,062 | +11.3% | 7.13% | +14.8% |
| BIIB | Sell | BIOGEN IDEC INC | $164,067,000 | +7.8% | 536,393 | -1.5% | 6.75% | +2.8% |
| GILD | Buy | GILEAD SCIENCES INC | $145,788,000 | -0.0% | 2,057,416 | +6.0% | 6.00% | -4.6% |
| TMO | Buy | THERMO FISHER SCI | $94,449,000 | +64.2% | 785,500 | +52.1% | 3.88% | +56.6% |
| REGN | Buy | REGENERON PHARMCTCLS | $92,306,000 | +21.5% | 307,400 | +11.4% | 3.80% | +15.9% |
| VRTX | Buy | VERTEX PHARMACEUTICL | $90,291,000 | -1.4% | 1,276,741 | +3.6% | 3.71% | -5.9% |
| ALXN | Buy | ALEXION PHARM INC | $83,368,000 | +26.4% | 548,008 | +10.4% | 3.43% | +20.6% |
| CELG | Sell | CELGENE CORP | $79,047,000 | -33.8% | 566,236 | -19.8% | 3.25% | -36.8% |
| TEVA | Buy | TEVA PHARMACEUTICALadr | $76,195,000 | +209.8% | 1,441,992 | +135.0% | 3.13% | +195.4% |
| INCY | Buy | INCYTE CORPORATION | $75,097,000 | +25.1% | 1,403,160 | +18.4% | 3.09% | +19.4% |
| HALO | Buy | HALOZYME THERAPEUTIC | $68,041,000 | -3.5% | 5,355,488 | +13.9% | 2.80% | -7.9% |
| MYL | Buy | MYLAN INC | $67,908,000 | +14.3% | 1,390,697 | +1.6% | 2.79% | +9.0% |
| BMRN | Buy | BIOMARIN PHARMAC INC | $63,258,000 | +26.0% | 927,406 | +29.9% | 2.60% | +20.1% |
| AGN | Sell | ALLERGAN INC | $61,622,000 | -1.2% | 496,548 | -11.5% | 2.54% | -5.7% |
| B108PS | Sell | ACTAVIS PLC | $60,510,000 | +17.3% | 293,950 | -4.3% | 2.49% | +11.9% |
| KERX | Buy | KERYX BIOPHARMACEUT | $60,281,000 | +68.7% | 3,537,590 | +28.2% | 2.48% | +60.9% |
| SHPG | Sell | SHIRE PLCsp adr | $58,104,000 | -12.3% | 391,197 | -16.5% | 2.39% | -16.3% |
| THRX | Sell | THERAVANCE INC | $57,273,000 | -18.6% | 1,851,088 | -6.2% | 2.36% | -22.3% |
| IRWD | Sell | IRONWOOD PHARMACEUCL | $57,192,000 | -3.1% | 4,642,182 | -8.7% | 2.35% | -7.6% |
| IMGN | Buy | IMMUNOGEN INC | $54,103,000 | +5.0% | 3,623,786 | +3.1% | 2.22% | +0.1% |
| OMED | Buy | ONCOMED PHARMACEUT | $45,348,000 | +25.9% | 1,347,642 | +10.5% | 1.86% | +20.1% |
| AEGR | New | AEGERION PHARMACEU | $43,137,000 | – | 934,100 | +100.0% | 1.77% | – |
| P103PS | Sell | NPS PHARMACEUTICALS | $42,163,000 | -21.8% | 1,408,729 | -20.6% | 1.73% | -25.4% |
| GEVA | Sell | SYNAGEVA BIOPHARMA | $38,593,000 | -19.3% | 465,145 | -37.1% | 1.59% | -23.1% |
| ISIS | Sell | ISIS PHARMACEUTICALS | $38,116,000 | -21.7% | 882,101 | -27.8% | 1.57% | -25.3% |
| MRK | Sell | MERCK & CO INC | $37,896,000 | -30.8% | 667,537 | -39.0% | 1.56% | -34.0% |
| ILMN | Buy | ILLUMINA INC | $36,420,000 | +56.3% | 244,989 | +16.3% | 1.50% | +49.1% |
| CLVS | Buy | CLOVIS ONCOLOGY | $34,178,000 | +20.0% | 493,400 | +4.4% | 1.41% | +14.5% |
| PTLA | Buy | PORTOLA PHARMACEUTIC | $31,397,000 | +21.7% | 1,212,245 | +21.0% | 1.29% | +16.1% |
| MNKKQ | Sell | MALLINCKRODT PLC | $28,710,000 | +20.9% | 452,764 | -0.4% | 1.18% | +15.3% |
| FRX | New | FOREST LABS INC | $24,922,000 | – | 270,100 | +100.0% | 1.02% | – |
| CLDX | Sell | CELLDEX THERAPEUTICS | $24,895,000 | -53.8% | 1,408,908 | -36.8% | 1.02% | -56.0% |
| PTCT | Buy | PTC THERAPEUTICS I | $24,778,000 | +2438.7% | 947,902 | +1548.0% | 1.02% | +2326.2% |
| ICPT | New | INTERCEPT PHARMACE | $24,567,000 | – | 74,493 | +100.0% | 1.01% | – |
| SGNT | Buy | SAGENT PHARMACEUTI | $24,270,000 | +38.6% | 1,038,504 | +50.6% | 1.00% | +32.2% |
| INSM | Sell | INSMED INC | $22,317,000 | -12.0% | 1,172,121 | -21.4% | 0.92% | -16.1% |
| UTHR | Buy | UNITED THERAPEUTICS | $22,041,000 | +7.1% | 234,400 | +28.8% | 0.91% | +2.1% |
| SGEN | Buy | SEATTLE GENETICS INC | $20,175,000 | +19.7% | 442,819 | +4.8% | 0.83% | +14.2% |
| RDY | Sell | DR REDDYS LABS LTDadr | $18,948,000 | +6.4% | 431,612 | -0.6% | 0.78% | +1.4% |
| VRX | New | VALEANT PHARMA INTL | $16,980,000 | – | 128,800 | +100.0% | 0.70% | – |
| AKRXQ | Sell | AKORN INC | $16,752,000 | -23.3% | 761,443 | -14.2% | 0.69% | -26.9% |
| F113PS | Sell | COVIDIEN PLC | $15,459,000 | -37.4% | 209,876 | -42.1% | 0.64% | -40.3% |
| ISRG | Sell | INTUITIVE SURGIC INC | $14,194,000 | -43.8% | 32,408 | -50.7% | 0.58% | -46.4% |
| ABBV | Sell | ABBVIE INC | $14,083,000 | -43.6% | 273,979 | -42.0% | 0.58% | -46.2% |
| BSX | Sell | BOSTON SCIENTIFIC | $13,780,000 | -45.4% | 1,019,221 | -51.5% | 0.57% | -47.9% |
| MNTA | Buy | MOMENTA PHARMACEUTIC | $12,941,000 | -18.2% | 1,110,797 | +24.2% | 0.53% | -22.0% |
| ALGN | Sell | ALIGN TECH INC | $10,206,000 | -44.4% | 197,072 | -38.6% | 0.42% | -46.9% |
| TRNX | Sell | TORNIER N Vordinar | $9,396,000 | -12.8% | 442,801 | -22.8% | 0.39% | -17.0% |
| HTWR | Sell | HEARTWARE INTL INC | $9,307,000 | -40.2% | 99,241 | -40.1% | 0.38% | -42.9% |
| NXTM | Sell | NXSTAGE MEDICAL | $6,325,000 | -16.0% | 496,465 | -34.1% | 0.26% | -20.0% |
| NVO | Buy | NOVO-NORDISK ASadr | $6,236,000 | +67.7% | 136,610 | +578.8% | 0.26% | +60.6% |
| INGN | New | INOGEN INC | $4,679,000 | – | 283,410 | +100.0% | 0.19% | – |
| ARAY | Sell | ACCURAY INC | $4,644,000 | -38.5% | 483,739 | -44.3% | 0.19% | -41.4% |
| DXCM | Sell | DEXCOM INC | $2,951,000 | -48.0% | 71,346 | -55.5% | 0.12% | -50.6% |
| NVS | Buy | NOVARTIS AGsp adr | $2,653,000 | +172.7% | 31,200 | +157.9% | 0.11% | +159.5% |
| EBIO | New | ELEVEN BIOTHERAPEU | $812,000 | – | 50,000 | +100.0% | 0.03% | – |
| ANTH | New | ANTHERA PHARMACEUT | $742,000 | – | 221,462 | +100.0% | 0.03% | – |
| GLYC | New | GLYCOMIMETICS INC | $728,000 | – | 44,587 | +100.0% | 0.03% | – |
| TNDM | Buy | TANDEM DIABETES CA | $665,000 | +29.1% | 30,100 | +50.5% | 0.03% | +22.7% |
| FPRX | New | FIVE PRIME THERAPE | $636,000 | – | 32,372 | +100.0% | 0.03% | – |
| LPTN | New | LPATH INC | $601,000 | – | 126,464 | +100.0% | 0.02% | – |
| TKMR | New | TEKMIRA PHARMACEU | $591,000 | – | 27,500 | +100.0% | 0.02% | – |
| AQXP | New | AQUINOX PHARMACEUT | $382,000 | – | 30,000 | +100.0% | 0.02% | – |
| WX | Buy | WUXI PHAR ADSsp adr | $247,000 | +7.4% | 6,690 | +11.5% | 0.01% | 0.0% |
| XLRN | Exit | ACCELERON PHARMA | $0 | – | -9,827 | -100.0% | -0.02% | – |
| KPTI | Exit | KARYOPHARM THERAPE | $0 | – | -35,000 | -100.0% | -0.04% | – |
| RLYP | Exit | RELYPSA INC | $0 | – | -50,000 | -100.0% | -0.05% | – |
| HOLX | Exit | HOLOGIC INC | $0 | – | -239,485 | -100.0% | -0.23% | – |
| PCYC | Exit | PHARMACYCLICS INC | $0 | – | -168,425 | -100.0% | -0.77% | – |
| MDVN | Exit | MEDIVATION INC | $0 | – | -388,760 | -100.0% | -1.07% | – |
| PRGO | Exit | PERRIGO CO | $0 | – | -327,268 | -100.0% | -2.17% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-05-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BIOMARIN PHARMAC INC | 42 | Q3 2023 | 6.7% |
| PTC THERAPEUTICS INC | 42 | Q3 2023 | 2.7% |
| DR REDDYS LABS LTD | 42 | Q3 2023 | 2.0% |
| GILEAD SCIENCES INC | 38 | Q3 2023 | 8.4% |
| INCYTE CORPORATION | 38 | Q3 2023 | 5.2% |
| VERTEX PHARMACEUTICL | 38 | Q3 2023 | 6.0% |
| AMICUS THERAPEUTICS INC | 37 | Q3 2023 | 6.6% |
| PFIZER INC | 35 | Q3 2023 | 6.3% |
| MERCK & CO. INC | 34 | Q3 2023 | 6.4% |
| MEDTRONIC PLC | 33 | Q3 2023 | 4.4% |
View SECTORAL ASSET MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aprea Therapeutics, Inc. | February 12, 2021 | 163,681 | 0.8% |
| LA JOLLA PHARMACEUTICAL CO | February 13, 2020 | ? | ? |
| COLLEGIUM PHARMACEUTICAL, INC | February 13, 2018 | 1,426,862 | 4.4% |
| Advaxis, Inc. | February 10, 2017 | 690,074 | 1.7% |
| AMICUS THERAPEUTICS INC | February 10, 2017 | 5,100,198 | 3.6% |
| OncoMed Pharmaceuticals Inc | February 12, 2016 | ? | ? |
| IRONWOOD PHARMACEUTICALS INC | February 13, 2015 | ? | ? |
| SEQUENOM INC | February 12, 2014 | ? | ? |
| INCYTE CORP | February 11, 2014 | 1,185,260 | 0.7% |
| INTERMUNE INC | February 11, 2014 | ? | ? |
View SECTORAL ASSET MANAGEMENT INC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| SC 13G/A | 2023-02-13 |
| SC 13G | 2023-02-13 |
| 13F-HR | 2023-02-10 |
| 13F-HR | 2022-11-10 |
View SECTORAL ASSET MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.